<a href="https://laohu8.com/S/MMSI">Merit Medical Systems</a> Reports Third-Quarter Revenue of $384.2 Million, Up 13%
Merit Medical Systems Inc. reported revenue of $384.2 million for the third quarter ended September 30, 2025, representing an increase of 13.0% compared to the same period in 2024. Constant currency revenue rose 12.5% year-over-year, while constant currency revenue, organic, increased 7.8%. The company reported a GAAP operating margin of 11.1%, up from 11.0% in the prior year period. Non-GAAP operating margin was 19.7%, compared to 19.2% in the previous year. GAAP earnings per share were $0.46, a decrease of 3.0%. Merit Medical Systems updated its full-year 2025 guidance, raising revenue and non-GAAP earnings per share expectations following the stronger-than-expected third quarter results. The company's President and CEO, Martha G. Aronson, affirmed Merit's commitment to growth initiatives and financial targets through 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merit Medical Systems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000856982-25-000055), on October 30, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。